229 related articles for article (PubMed ID: 3927506)
1. Platelet regeneration time after aspirin ingestion and platelet survival time after labelling with 51chromium or 111indium oxine--a comparative study.
Boneu A; Sié P; Bugat R; Caranobe C; Eber M; Cazenave JP; Boneu B
Thromb Haemost; 1985 Apr; 53(2):260-3. PubMed ID: 3927506
[TBL] [Abstract][Full Text] [Related]
2. Comparison of oxine and tropolone methods for labeling human platelets with indium-111.
Kotzé HF; Heyns AD; Lötter MG; Pieters H; Roodt JP; Sweetlove MA; Badenhorst PN
J Nucl Med; 1991 Jan; 32(1):62-6. PubMed ID: 1899112
[TBL] [Abstract][Full Text] [Related]
3. Platelet deposition at angioplasty sites and platelet survival time after PTA in iliac and femoral arteries: investigations with indium-111-oxine labelled platelets in patients with ASA (1.0 g/day)-therapy.
Minar E; Ehringer H; Ahmadi R; Dudczak R; Porenta G
Thromb Haemost; 1987 Aug; 58(2):718-23. PubMed ID: 2960029
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of mathematic models to assess platelet kinetics.
Lötter MG; Heyns AD; Badenhorst PN; Wessels P; Martin van Zyl J; Kotze HF; Minnaar PC
J Nucl Med; 1986 Jul; 27(7):1192-201. PubMed ID: 3088224
[TBL] [Abstract][Full Text] [Related]
5. Indium-111 platelet kinetics in normal human subjects: tropolone versus oxine methods.
Vallabhajosula S; Machac J; Goldsmith SJ; Lipszyc H; Badimon L; Rand J; Fuster V
J Nucl Med; 1986 Nov; 27(11):1669-74. PubMed ID: 3095509
[TBL] [Abstract][Full Text] [Related]
6. A quantitative study of indium-111-oxine platelet kinetics in acute and chronic renal transplant rejection.
Heyns AD; Lötter MG; Pieters H; Pauw FH; Badenhorst PN; Wessels P; Minnaar PC
Clin Nephrol; 1982 Oct; 18(4):174-82. PubMed ID: 6814802
[TBL] [Abstract][Full Text] [Related]
7. Labeling of platelets with oxine complexes of Tc-99m and In-111. Part 1. In vitro studies and survival in the rabbit.
Wistow BW; Grossman ZD; McAfee JG; Subramanian G; Henderson RW; Roskopf ML
J Nucl Med; 1978 May; 19(5):483-7. PubMed ID: 417153
[TBL] [Abstract][Full Text] [Related]
8. Preparation of a viable population of indium-111-labelled human blood platelets.
Heyns AD; Badenhorst PN; Pieters H; Lötter MG; Minnaar PC; Duyvené de Wit LJ; Van Reenen OR; Retief FP
Thromb Haemost; 1980 Feb; 42(5):1473-82. PubMed ID: 6768151
[TBL] [Abstract][Full Text] [Related]
9. [Technic of radioactive labeling of autologous human thrombocytes using 111-indium-oxine and 111-indium-oxine-sulfate and their clinical use].
Jäger E; Kolbe H; Silberbauer K; Sinzinger H; Höfer R
Wien Klin Wochenschr; 1984 Feb; 96(3):106-12. PubMed ID: 6426171
[TBL] [Abstract][Full Text] [Related]
10. Measurements of cell-mediated cytotoxicity on target cells labelled with the indium-111-oxine complex.
Smet-Donnay M; Guillaume M; Schaaf-Lafontaine N; Czichosz R; Firket H
Ann Biol Clin (Paris); 1985; 43(3):285-8. PubMed ID: 3161437
[TBL] [Abstract][Full Text] [Related]
11. [Initial experience with autologous thrombocytes labeled with 111indium-oxine].
Fikrle A; Knedlhansová I; Suchý M; Cepelák V; Slípková D; Klecka J; Valenta J
Cas Lek Cesk; 1989 Feb; 128(8):238-44. PubMed ID: 2497987
[TBL] [Abstract][Full Text] [Related]
12. A comparison of two methods of labelling autologous platelets with 111In-oxine in five different species.
Christenson JT; Arvidsson D; Thörne J; Olsson PI; Norgren L; Strand SE
Eur J Nucl Med; 1983; 8(9):389-92. PubMed ID: 6414817
[TBL] [Abstract][Full Text] [Related]
13. Effect of acetaminophen on the leukocyte-labeling efficiency of indium oxine In 111.
Augustine SC; Schmelter RF; Nelson KL; Petersen RJ; Qualfe MA
Am J Hosp Pharm; 1983 Nov; 40(11):1965-7. PubMed ID: 6418003
[TBL] [Abstract][Full Text] [Related]
14. [In vitro and in vivo studies using 111 indium oxine, 111 indium oxine sulfate and 99m Tc oxine in erythrocyte labeling].
Reiter S; Angelberger P; Kolbe H; Sinzinger H
Wien Klin Wochenschr; 1984 Feb; 96(3):120-3. PubMed ID: 6426172
[TBL] [Abstract][Full Text] [Related]
15. Indium-111 oxine platelet survival in dogs: effect of doxorubicin and Dacron grafts.
Rauls DO; Moreno AJ; Gregory G; Penney LL; Parker G; Collins J; Daniels JR
J Nucl Med; 1985 Nov; 26(11):1331-4. PubMed ID: 2932543
[TBL] [Abstract][Full Text] [Related]
16. A study of leucocyte labelling efficiencies obtained with 111In-oxine.
Mountford PJ; Allsopp MJ; Baird AC; North CI; Hall FM; Wells CP; Coakley AJ
Nucl Med Commun; 1985 Feb; 6(2):109-14. PubMed ID: 3939730
[TBL] [Abstract][Full Text] [Related]
17. [Platelet labelling with In-111-oxine: platelet survival and the images].
Conte G; González P; Larraín C; Olea E; Parada X; Hurtado E; Cuneo M
Rev Med Chil; 1990 Jan; 118(1):10-4. PubMed ID: 2152696
[TBL] [Abstract][Full Text] [Related]
18. [Preparation of 111indium oxinate from 111indium chloride].
Kleinert P; Endert G
Radiobiol Radiother (Berl); 1988; 29(2):205-7. PubMed ID: 3135557
[No Abstract] [Full Text] [Related]
19. Contribution of contaminant indium-114m/indium-114 to indium-111 oxine blood dosimetry.
Marcus CS; Stabin MG; Watson EE; Kuperus JH
J Nucl Med; 1985 Sep; 26(9):1091-3. PubMed ID: 3928839
[TBL] [Abstract][Full Text] [Related]
20. Kinetics, distribution, and sites of destruction of canine blood platelets with In-111 oxine.
Lötter MG; Badenhorst PN; Heyns AD; Van Reenen OR; Pieters H; Minnaar PC
J Nucl Med; 1980 Jan; 21(1):36-40. PubMed ID: 6766182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
